REGN
$REGN
Regeneron Pharmaceuticals
Biotech company known for Eylea and Dupixent immunology drugs.
Healthcare$761.87
-15.38 (-1.98%)
Day Range$745.00 - $770.11
Prev Close$777.25
Analyst Rating
Strong Buy
30 Buy / 8 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Apr 5
Weekly updates
Latest Report
REGN: Dupixent Approval and Valuation Outlook
Regeneron ($REGN) shows solid fundamentals, a clean balance sheet, and fresh regulatory wins for Dupixent in Japan. Analysts remain constructive while competition and pipeline execution remain key risks to monitor.
Mar 30, 2026